| Product Code: ETC5821345 | Publication Date: Nov 2023 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Portugal`s biologics import market continued to witness significant growth in 2024, with top countries such as the Netherlands, Spain, USA, Sweden, and the UK dominating the export landscape. The industry experienced a notable increase in market concentration, reaching a very high level in 2024 compared to the previous year. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) from 2020 to 2024 remained impressive at 56.26%, indicating a strong and steady demand for biologics in Portugal.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Biologics Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Biologics Market Revenues & Volume, 2022 & 2032F |
3.3 Portugal Biologics Market - Industry Life Cycle |
3.4 Portugal Biologics Market - Porter's Five Forces |
3.5 Portugal Biologics Market Revenues & Volume Share, By Source, 2022 & 2032F |
3.6 Portugal Biologics Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.7 Portugal Biologics Market Revenues & Volume Share, By Disease? Category, 2022 & 2032F |
3.8 Portugal Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2022 & 2032F |
4 Portugal Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Portugal |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Favorable government regulations promoting biologics research and development |
4.3 Market Restraints |
4.3.1 High cost associated with biologics development and production |
4.3.2 Stringent regulatory requirements for approval and market access |
4.3.3 Limited reimbursement policies for biologics in Portugal |
5 Portugal Biologics Market Trends |
6 Portugal Biologics Market Segmentations |
6.1 Portugal Biologics Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Portugal Biologics Market Revenues & Volume, By Microbial, 2022 - 2032F |
6.1.3 Portugal Biologics Market Revenues & Volume, By Mammalian, 2022 - 2032F |
6.1.4 Portugal Biologics Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 Portugal Biologics Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Portugal Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2022 - 2032F |
6.2.3 Portugal Biologics Market Revenues & Volume, By Vaccines, 2022 - 2032F |
6.2.4 Portugal Biologics Market Revenues & Volume, By Recombinant Proteins, 2022 - 2032F |
6.2.5 Portugal Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2022 - 2032F |
6.2.6 Portugal Biologics Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 Portugal Biologics Market, By Disease? Category |
6.3.1 Overview and Analysis |
6.3.2 Portugal Biologics Market Revenues & Volume, By Oncology, 2022 - 2032F |
6.3.3 Portugal Biologics Market Revenues & Volume, By Infectious Diseases, 2022 - 2032F |
6.3.4 Portugal Biologics Market Revenues & Volume, By Immunological Disorders, 2022 - 2032F |
6.3.5 Portugal Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2022 - 2032F |
6.3.6 Portugal Biologics Market Revenues & Volume, By Hematological Disorders, 2022 - 2032F |
6.3.7 Portugal Biologics Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 Portugal Biologics Market, By Biologics Manufacturing |
6.4.1 Overview and Analysis |
6.4.2 Portugal Biologics Market Revenues & Volume, By Outsourced, 2022 - 2032F |
6.4.3 Portugal Biologics Market Revenues & Volume, By In-house, 2022 - 2032F |
7 Portugal Biologics Market Import-Export Trade Statistics |
7.1 Portugal Biologics Market Export to Major Countries |
7.2 Portugal Biologics Market Imports from Major Countries |
8 Portugal Biologics Market Key Performance Indicators |
8.1 Research and development investment in biologics by pharmaceutical companies |
8.2 Number of clinical trials and approvals for new biologic products in Portugal |
8.3 Adoption rate of biologics in the treatment of chronic diseases in the country |
9 Portugal Biologics Market - Opportunity Assessment |
9.1 Portugal Biologics Market Opportunity Assessment, By Source, 2022 & 2032F |
9.2 Portugal Biologics Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.3 Portugal Biologics Market Opportunity Assessment, By Disease? Category, 2022 & 2032F |
9.4 Portugal Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2022 & 2032F |
10 Portugal Biologics Market - Competitive Landscape |
10.1 Portugal Biologics Market Revenue Share, By Companies, 2025 |
10.2 Portugal Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here